Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Full IRB Study Title:
ANBL1232: Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-high-risk Neuroblastoma
IRB Study ID: 1021250-1
For complete study information, please view the study on clinicaltrials.gov
We are currently recruiting
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org